PRO-DRUGS AS DRUG DELIVERY SYSTEMS .11. PREPARATION AND CHARACTERIZATION OF A NOVEL WATER-SOLUBLE PRO-DRUG TYPE FOR BARBITURIC-ACIDS

被引：6

作者：

BUNDGAARD, H ^{[1
]}

FALCH, E ^{[1
]}

LARSEN, C ^{[1
]}

机构：

[1] ROYAL DANISH SCH PHARM,DEPT CHEM,DK-2100 COPENHAGEN O,DENMARK

来源：

关键词：

D O I：

10.1016/0378-5173(80)90026-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：19 / 27

页数：9

共 19 条

[11] LEUCUTA SE, 1977, PHARM ACTA HELV, V52, P261
[12] PEARCE JL, 1977, PEDIATRICS, V60, P569
[13] SCHLEMMER W, 1979, ACTA PHARM TECHNOL, V25, P81
[14] SINGH P, 1966, J PHARM SCI-US, V55, P63
[15] SJOGREN J, 1965, ACTA MED SCAND, V178, P553
[16] ESTERS OF HYDANTOIC ACIDS AS PRODRUGS OF HYDANTOINS
STELLA, V
HIGUCHI, T
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (06) : 962 - 967
[17] STELLA V, 1975, PRODRUGS NOVEL DRUG, P154
[18] INTRAMUSCULAR INJECTIONS AND BIOAVAILABILITY
TUTTLE, CB
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (09): : 965 - 968
[19] BIOAVAILABILITY OF ORAL AND INTRAMUSCULAR PHENOBARBITAL
VISWANATHAN, CT
BOOKER, HE
WELLING, PG
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 18 (2-3) : 100 - 105